ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK GSK plc

45.59
-0.07 (-0.15%)
Pre Market
Last Updated: 09:26:51
Delayed by 15 minutes
Name Symbol Market Type
GSK plc NYSE:GSK NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  -0.07 -0.15% 45.59 2,355 09:26:51

GSK's RSV Vaccine Approved for Older Adults by FDA

03/05/2023 6:43pm

Dow Jones News


GSK (NYSE:GSK)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more GSK Charts.

By Joe Hoppe

 

GSK PLC said late Wednesday that its Arexvy respiratory syncytial virus vaccine for older adults has been approved by the U.S. Food and Drug Administration for the prevention of lower respiratory tract disease.

The pharmaceutical major said the approval--based upon positive Phase 3 trial data that showed exceptional efficacy in older adults--is the first in the world to be approved for individuals aged 60 years or older.

In the trial, the vaccine showed statistically significant and clinically meaningful overall efficacy, including among those with underlying medical conditions and those with severe RSV disease, and was well tolerated with an acceptable safety profile.

"Our focus now is to ensure eligible older adults in the U.S. can access the vaccine as quickly as possible and to progress regulatory review in other countries," GSK Chief Scientific Officer Tony Wood said.

The drug is expected to be launched in the U.S. before the 2023-2024 RSV season.

RSV is a common, contagious virus that can lead to potentially serious respiratory illness, causing an estimated 14,000 deaths in the U.S. in adults aged 65 years and older each year.

 

Write to Joe Hoppe at joseph.hoppe@wsj.com

 

(END) Dow Jones Newswires

May 03, 2023 13:28 ET (17:28 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year GSK Chart

1 Year GSK Chart

1 Month GSK Chart

1 Month GSK Chart

Your Recent History

Delayed Upgrade Clock